Angiotensin II drives the production of tumor-promoting macrophages.
about
Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissuesTumor associated macrophage: a review on the phenotypes, traits and functionsThe spleen in local and systemic regulation of immunitySphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor MicroenvironmentTracking of intertissue migration reveals the origins of tumor-infiltrating monocytes.Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes.The journey from stem cell to macrophage.Chemotherapy and tumor microenvironment of pancreatic cancer.IκB kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm.Inflammatory monocytes determine endothelial nitric-oxide synthase uncoupling and nitro-oxidative stress induced by angiotensin IILifestyle effects on hematopoiesis and atherosclerosis.Gut microbiome and anticancer immune response: really hot Sh*t!Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells/progenitors through endothelial AT₂R and cytoskeletal dysregulation.Ordered cleavage of myeloperoxidase ester bonds releases active site heme leading to inactivation of myeloperoxidase by benzoic acid hydrazide analogs.Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton.The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growthA map of the distribution of sphingosine 1-phosphate in the spleenAngiotensin converting enzyme inhibitors and angiotensin II receptor antagonist attenuate tumor growth via polarization of neutrophils toward an antitumor phenotypeMonocyte and macrophage contributions to cardiac remodeling.Molecular pathways: tumor-derived microvesicles and their interactions with immune cells in vivoEffect of CD16a, the surface receptor of Kupffer cells, on the growth of hepatocellular carcinoma cells.MicroRNA-mediated control of macrophages and its implications for cancerRole of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndromeInflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters.Central and peripheral nervous systems: master controllers in cancer metastasis.From proliferation to proliferation: monocyte lineage comes full circle.Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins.Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy.Applying nanomedicine in maladaptive inflammation and angiogenesis.Spleen contributes to restraint stress induced changes in blood leukocytes distributionTumor-secreted products repress B-cell lymphopoiesis in a murine model of breast cancer.The role of myeloid cells in cancer therapies.Pro-tumor activities of macrophages in the progression of melanoma.Remote control of macrophage production by cancer.PF4 Promotes Platelet Production and Lung Cancer Growth.The importance of student initiative both in and out of the lab: the second immunobiology student symposium.Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma.Roles of renin-angiotensin system and Wnt pathway in aging-related phenotypes.Alveolar injury and regeneration following deletion of ABCA3.
P2860
Q27003907-CF9C94A2-48B5-45C3-904C-DC3B6FCDB453Q27010428-C71F08F1-4363-4A19-88C1-A860EE0C5FB5Q27025001-D8373AC7-A205-4191-B5BE-02F78F99A46EQ28069459-6523DBC0-A654-4F5F-8E57-18A99E3C4A98Q33694661-583E8AC4-AF52-4C00-8391-3DD01A7FC000Q33782573-6907A1AC-5E6C-4446-85CA-85AFFE40BC3CQ33817936-A89A671E-445A-4DD7-AB96-1122C42E5F5DQ33876637-A19674C0-BB44-4F3E-85EB-A70F73ECD228Q33940685-585EE1B3-F220-4B44-A1C1-917F3A457A51Q34283413-B8B162E2-958C-4B4A-8D89-E899F6A87BDEQ34668164-7717A403-D7EC-4975-B355-8C44205D2BE5Q34924272-BD654DFD-303E-466C-9363-40342A7AB62CQ34940868-61E424DB-EF21-49E4-8DEC-53A59AF34C0FQ35108758-02D319C3-48D6-4DEB-90A9-884B93E334ADQ35588952-D3B0CB0E-AAD1-4230-8C6B-CC5E06C41F57Q36072831-F24A9682-CB04-49DE-9B51-9C2AAC6775C1Q36402427-33D9B8E7-3DD8-4E3C-A2E8-872FE22B50A9Q36597484-5FEA3C23-1770-4DC0-B2F9-E84E8E7A115FQ36840151-6B9D040E-5043-4B29-B2F3-8E58A28613C7Q36847231-A5DCFC48-01DE-4710-AD60-789A28E85C6CQ36901142-828BC7FE-501D-4047-8E36-DB7329FC16A2Q36980007-0D4E1AE0-BAB4-43C7-AD3D-217D499BD899Q37462103-E678B1A7-19FB-4932-80AB-96B6CD0DF90CQ37618229-B6785EF3-FB70-489C-B0F2-29C62770B251Q38106901-A8F46802-B808-4DAA-A0C1-5D54216F9584Q38179249-FFA92A6A-D134-4669-8122-66A1B72FCB09Q38190099-3E2DEDF9-FBAC-47CB-955F-8EDF6B3143A7Q38380871-13A8629C-85B0-47C4-B874-052C5494A4ABQ38548339-E57F97D9-2392-40FE-908D-757F2EA9B923Q38557650-87F595C8-BC54-40F3-9CE6-5DC35916B1A5Q38659213-38673D9D-407E-4D35-82BB-13AC20582A45Q38746775-4490884D-5E5E-44AE-9EB7-00330B446903Q38875474-31AAC9FE-00B8-4384-AEEA-1B41CF7A323CQ39261360-751A5DD9-5D23-479A-B89E-C0E9457C0E5BQ41219799-469CEE40-69EA-4D05-9D7C-B796AEA6BD67Q41849208-492BCAEE-613D-4264-A3D8-7B7B0ECF2B84Q42425381-6561C8CE-A66E-47EB-A101-5F790BFBF110Q42776799-31942157-585B-40D2-BF5D-3BD18054C1D1Q47132051-DEF47ECB-5B4D-48C8-BD08-39AE4C69366EQ47268961-D719443E-F725-4ACA-B17D-D20D3F1DBDE4
P2860
Angiotensin II drives the production of tumor-promoting macrophages.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Angiotensin II drives the production of tumor-promoting macrophages.
@en
Angiotensin II drives the production of tumor-promoting macrophages.
@nl
type
label
Angiotensin II drives the production of tumor-promoting macrophages.
@en
Angiotensin II drives the production of tumor-promoting macrophages.
@nl
prefLabel
Angiotensin II drives the production of tumor-promoting macrophages.
@en
Angiotensin II drives the production of tumor-promoting macrophages.
@nl
P2093
P2860
P50
P1433
P1476
Angiotensin II drives the production of tumor-promoting macrophages.
@en
P2093
Aleksey Chudnovskiy
Andita Newton
Brett Marinelli
Ferdinando Pucci
Gregory Wojtkiewicz
John W Chen
Jose-Luiz Figueiredo
Mari Mino-Kenudson
Matthias Nahrendorf
Mikael J Pittet
P2860
P304
P356
10.1016/J.IMMUNI.2012.10.015
P407
P577
2013-01-17T00:00:00Z